GLMD

Galmed Pharmaceuticals Ltd

NASDAQ

Add Alert

GLMD

Galmed Pharmaceuticals Ltd

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

Awl416

03/15/24 9:04 AM

Post #112

Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis

Monksdream PremiumMember

10/25/23 3:10 PM

Post #111

GLMD new 52=week low

Monksdream PremiumMember

10/05/23 7:50 AM

Post #110

GLMD new 52 week low

Monksdream PremiumMember

09/26/23 3:17 PM

Post #109

GLMD new 52 week low

Monksdream PremiumMember

09/14/23 2:57 PM

Post #108

GLMD new 52 week low

Monksdream PremiumMember

08/18/23 1:26 PM

Post #107

GLMD new 52 week low

Monksdream PremiumMember

08/16/23 1:22 PM

Post #106

GLMD new 52 low

Monksdream PremiumMember

08/07/23 2:16 PM

Post #105

GLMD new 52 week low

surf1944

07/14/23 12:27 PM

Post #104

Re: #97: @surf1944 - https://stockcharts.com/h-sc/ui?s=glmd&p=D&yr=0&mn=6&dy=0&id=p38090673899 htt

https://stockcharts.com/h-sc/ui?s=glmd&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/glmd/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/glmd/opinion

https://finance.yahoo.com/quote/GLMD?p=GLMD

https://www.nasdaq.com/market-activity/spos

$1.25 offering

Triple nickle Free

07/13/23 9:00 AM

Post #103

Lol caught a falling knife

AJ Freely

07/13/23 8:59 AM

Post #102

$GLMD - ??Up 20% Pre-Market/ Current Price $2.91
To employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC

Awl416

07/12/23 12:05 PM

Post #101

Woot woot

Golden Cross Free

05/09/23 10:59 AM

Post #100

Re: #99: @HoldEm777 - https://www.prnewswire.com/news-releases/galmed-announces-initiation-of-a-clinic

Nice

Bullish

HoldEm777

05/09/23 10:35 AM

Post #99

Re: #96: @Golden Cross - $GLMD Galmed Pharmaceuticals forms a Strategic Partnership with OnKai

https://www.prnewswire.com/news-releases/galmed-announces-initiation-of-a-clinical-development-program-to-evaluate-aramchol-meglumine-for-the-treatment-of-primary-sclerosing-cholangitis-psc-301819268.html

HoldEm777

05/07/23 2:28 PM

Post #98

Re: #97: @surf1944 - https://stockcharts.com/h-sc/ui?s=glmd&p=D&yr=0&mn=6&dy=0&id=p38090673899 htt

https://ih.advfn.com/stock-market/NASDAQ/galmed-pharmaceuticals-GLMD/historical

surf1944

05/07/23 10:51 AM

Post #97

Golden Cross Free

05/04/23 4:45 PM

Post #96

Re: #95: @madras50 - any idea what the deal is here?

$GLMD Galmed Pharmaceuticals forms a Strategic Partnership with OnKai

https://galmedpharma.investorroom.com/2023-05-04-Galmed-Pharmaceuticals-forms-a-Strategic-Partnership-with-OnKai

madras50

05/04/23 4:32 PM

Post #95

Re: #94: @SmokeSignals - wow!

any idea what the deal is here?

SmokeSignals Free

05/04/23 4:31 PM

Post #94

wow!

Bullish

ZZZ888

12/21/22 8:52 PM

Post #93

Wow no one posted anything on this move today shocker

now invest Free

06/04/21 12:10 PM

Post #92

Decent move ..thus far today!! Like it!!

now invest Free

03/16/21 8:56 AM

Post #91

Ah... news... starting dosing!!..

now invest Free

02/14/21 3:52 PM

Post #90

Re: #89: @swagman - I agree ... better to have strong institutional

Well.... guess it depends on definitions!! I see a 20-40 % gain in less than 4-6 months!! The more than 3x some are expecting.... will probably be longer!!

swagman

02/13/21 9:01 AM

Post #89

Re: #88: @now invest - Nice day again!! And no interest here!!

I agree ... better to have strong institutional interest (as per recent activity after KOL event) than here but I think it'll still be a year or so before this stock really takes off

now invest Free

02/11/21 2:00 PM

Post #88

Nice day again!! And no interest here!! HEY ok with me!! LOL

now invest Free

02/03/21 3:32 PM

Post #87

Nice move today!! Nice volume also!!

Vader69

12/16/20 4:32 AM

Post #86

Volume was up 3x normal yesterday on 12/15. The 100 day moving average was also breached suggestive of something cooking. Very exciting company; interesting to see where this goes

ClayTrader Free

12/04/19 6:08 PM

Post #85

* * $GLMD Video Chart 12-04-2019 * *

Link to Video - click here to watch the technical chart video

DewDiligence PremiumMember

11/13/18 12:30 PM

Post #84

GLMD phase-2b data NASH data:

https://finance.yahoo.com/news/phase-2-data-galmed-pharmaceuticals-163000034.html

DewDiligence PremiumMember

11/05/18 9:08 AM

Post #83

Re: #80: @DewDiligence - GLMD 2Q18 results:

GLMD 3Q18 results—cash=$92.3M:

https://finance.yahoo.com/news/galmed-pharmaceuticals-provides-business-reports-120000693.html

Amatuer17

08/04/18 10:24 PM

Post #82

Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q2 2018 Results - Earnings Call Transcript $GLMD

https://seekingalpha.com/article/4194869

The final cost of the trial will be around $75 million
200 centers
Start by Q2-2019
Duration 52 weeks
No of patients - around 300

Study enrollment may take 12-18 months + 12 months + 3-4 months for topline results - we are looking at 32-36 months or 3 years - which is Q2-2022

If there is no buyout or partnership - we will see just dilution and SP going down

DewDiligence PremiumMember

08/02/18 11:51 AM

Post #81

Re: #80: @DewDiligence - GLMD 2Q18 results:

GLMD 2Q18 CC notes re phase-3 NASH trial:

https://twitter.com/DewDiligence/status/1025045825884438530

DewDiligence PremiumMember

08/02/18 10:12 AM

Post #80

Re: #72: @DewDiligence - GLMD sells 5.75M* shares @$15.00—a 9% discount to

GLMD 2Q18 results:

https://finance.yahoo.com/news/galmed-pharmaceuticals-provides-business-reports-110000942.html

6/30/18 cash was $94.1M.

conix

07/15/18 8:20 AM

Post #79

Re: #78: @investor86 - Thinking to put 20k in it for long

GLMD chart

investor86 Free

07/13/18 2:56 PM

Post #78

Re: #76: @crudeoil24 - 15.39 > very bullish!

Thinking to put 20k in it for long run. Raitings are great.

crudeoil24 PremiumMember

07/13/18 11:35 AM

Post #77

Re: #76: @crudeoil24 - 15.39 > very bullish!

Galmed Notches Second Bullish Rating On Aramchol Opportunity
10:49 am ET July 13, 2018 (Benzinga) Print
Two days after Cantor Fitzgerald gave Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) a shot in the arm with an ultrabullish rating, Stifel Nicolaus administered a booster.

Galmed spiked 15 percent Friday morning after already having risen 21 percent in the preceding session.

The Analyst

Stifel analyst Adam Walsh initiated coverage of Galmed with a Buy rating and $35 price target.

The Thesis

As with Cantor Fitzgerald, Galmed’s Aramchol was again the point of optimism.

Walsh considers the candidate a multibillion-dollar opportunity for the treatment of non-alcoholic steatohepatitis, or NASH, and forecast a “decent chance” of an Aramchol partnership deal materializing ahead of the Phase 3 trial launch in the first half of 2019. (See Walsh's track record here.)

“We think large-pharma validation could drive shares significantly higher,” the analyst said.

With positive Phase 2b results failing to stimulate the stock, Stifel said the Street overlooked Aramchol’s strengths and thereby created a buying opportunity.

Aramchol did not reach statistical significance on either of two approvable endpoints — but they were secondary endpoints and were not powered for statistics, Walsh said.

“While Aramchol did not hit statistical significance on either of the two approvable endpoints, we remind investors that these “Despite this, Aramchol nearly hit on NASH resolution without worsening of fibrosis and showed strong trends on the fibrosis improvement with no worsening of NASH.”

The analyst expects the next phase to generate the statistically significant data investors demand.

After conversations with management, Walsh rejected concerns over dropout rates and competition from Madrigal Pharmaceuticals Inc (NASDAQ: MDGL).

Price Action

Galmed shares were rallying 16.27 percent to $14.85 at the time of publication Friday morning.

Related Links:

Galmed Shares More Than Double As It Hits Bullseye With Fatty Liver Candidate

Zogenix Soars On Positive Phase 3 Data In Dravet Syndrome Study

Photo by Nephron/Wikimedia.

Latest Ratings for GLMD DateFirmActionFromTo

Jul 2018Stifel NicolausInitiates Coverage OnBuy Jul 2018Cantor FitzgeraldInitiates Coverage OnOverweight Jun 2018Maxim GroupMaintainsBuyBuy

crudeoil24 PremiumMember

07/13/18 11:15 AM

Post #76

Re: #75: @crudeoil24 - Heading back to $20.00+ very,very,soon!

15.39 > very bullish!

crudeoil24 PremiumMember

07/13/18 10:24 AM

Post #75

Re: #74: @crudeoil24 - Galmed Pharmaceuticals started at buy with $35 stock

Heading back to $20.00+ very,very,soon!

crudeoil24 PremiumMember

07/13/18 8:44 AM

Post #74

Re: #73: @crudeoil24 - Price Target Announced at $59.00/Share by Cantor Fitzgerald

Galmed Pharmaceuticals started at buy with $35 stock price target at Stifel Nicolaus
7:26 am ET July 13, 2018 (MarketWatch)
Share
Print
(END) Dow Jones Newswires

July 13, 2018 07:26 ET (11:26 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

crudeoil24 PremiumMember

07/12/18 7:53 AM

Post #73

Re: #72: @DewDiligence - GLMD sells 5.75M* shares @$15.00—a 9% discount to

Price Target Announced at $59.00/Share by Cantor Fitzgerald

Ratings actions from Benzinga: http://www.benzinga.com/stock/GLMD/ratings

(END) Dow Jones Newswires

July 11, 2018 16:24 ET (20:24 GMT)

DewDiligence PremiumMember

06/20/18 11:12 AM

Post #72

Re: #70: @DewDiligence - GLMD seeking $86.3M* on unspecified terms:

GLMD sells 5.75M* shares @$15.00—a 9% discount to last Friday’s close:

https://finance.yahoo.com/news/galmed-pharmaceuticals-ltd-announces-pricing-013700954.html

Net proceeds from the offering will be about $81M*.

*Assuming exercise of underwriter’s option.

DewDiligence PremiumMember

06/18/18 9:32 AM

Post #71

Re: #70: @DewDiligence - GLMD seeking $86.3M* on unspecified terms:

GLMD updates patent information:

https://www.sec.gov/Archives/edgar/data/1595353/000114420418034494/tv496661_ex99-3.htm

DewDiligence PremiumMember

06/18/18 9:30 AM

Post #70

Re: #64: @DewDiligence - GLMD PR on phase-2b ARREST study in NASH:

GLMD seeking $86.3M* on unspecified terms:

https://www.sec.gov/Archives/edgar/data/1595353/000114420418034494/tv496661_ex99-2.htm

A new corporate slide deck has been issued to accompany the above PR:
https://www.sec.gov/Archives/edgar/data/1595353/000114420418034494/tv496661_ex99-1.htm

*Assuming exercise of underwriter’s option.

cjstocksup PremiumMember

06/12/18 12:35 PM

Post #69

Re: #67: @cjstocksup - Back in here in the 19's and 20's

Out at $21.20's. GL everyone.

dirtydozen911 Free

06/12/18 11:47 AM

Post #68

shorted a handfull at $22...just got out when she dipped under $19...may go long later.....glta

cjstocksup PremiumMember

06/12/18 11:12 AM

Post #67

Re: #66: @Awl416 - I was waiting for your pal CJ to

Back in here in the 19's and 20's for round 2 ahead. Todays run from pre market $10 to $12 to over $27.00 after the open was insane! Hope we do it again this afternoon. The float is gone now. Looks like the walkdown is buyers with tight stop losses on the drop;